Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden
Genetic Subtype Identification Identifying genetic subtypes of multiple sclerosis (MS) is a pivotal aspect of understanding the heterogeneity of the […]
Carabrone alleviates neuroinflammation by covalently targeting ubiquitin conjugating enzyme UBE2D3 in experimental autoimmune encephalomyelitis
Study Overview This study investigates the role of Carabrone, a compound that has demonstrated potential in alleviating neuroinflammation, particularly within
Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden
Genetic Subtypes and Their Impact Multiple sclerosis (MS) is a complex neurological condition with a myriad of clinical presentations and
Validation of a human peripheral neuronal model for ATP-P2X3 mediated inflammatory pain signalling in the dental pulp
Study Overview The study focuses on the validation of a human peripheral neuronal model that is used to investigate ATP-P2X3
Mapping concussion-induced cerebellar injury: a personalized approach using diffusion tensor imaging (DTI)
Study Overview This study investigates the impact of concussion on the cerebellum, specifically examining the associated injuries through advanced imaging
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study
Study Overview The study was designed as a phase 2b clinical trial to evaluate the efficacy and safety of rezpegaldesleukin
Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis
Study Overview This research aimed to assess and compare the efficacy and safety of three-month versus twelve-month dual antiplatelet therapy
Editorial. Improving the management of polytrauma patients admitted with mild traumatic brain injury
Management Strategies for Polytrauma Effective management of polytrauma patients, particularly those presenting with mild traumatic brain injury (mTBI), requires a
Cladribine treatment in chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: two case reports
Study Overview The study presents two distinct cases where Cladribine, a drug primarily used in the treatment of certain types
Combined clemastine fumarate and selenomethionine promote remyelination via PI3K/Akt/mTOR signaling in experimental multiple sclerosis
Therapeutic Potential of Combined Treatments Recent advancements in multiple sclerosis (MS) treatment emphasize the significance of combining therapeutics to enhance